###begin article-title 0
Brabykinin B1 Receptor Antagonism Is Beneficial in Renal Ischemia-Reperfusion Injury
###end article-title 0
###begin p 1
###xml 86 89 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 124 127 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 206 209 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
Conceived and designed the experiments: PHMW NOSC. Performed the experiments: PHMW GC MAC CF GG. Analyzed the data: PHMW GC MAC CF GG RL SJ JBP APS NOSC. Contributed reagents/materials/analysis tools: PHMW MAC RL SJ JBP APS. Wrote the paper: PHMW NOSC.
###end p 1
###begin p 2
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">B1KO</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
Previously we have demonstrated that bradykinin B1 receptor deficient mice (B1KO) were protected against renal ischemia and reperfusion injury (IRI). Here, we aimed to analyze the effect of B1 antagonism on renal IRI and to study whether B1R knockout or antagonism could modulate the renal expression of pro and anti-inflammatory molecules. To this end, mice were subjected to 45 minutes ischemia and reperfused at 4, 24, 48 and 120 hours. Wild-type mice were treated intra-peritoneally with antagonists of either B1 (R-954, 200 microg/kg) or B2 receptor (HOE140, 200 microg/kg) 30 minutes prior to ischemia. Blood samples were collected to ascertain serum creatinine level, and kidneys were harvested for gene transcript analyses by real-time PCR. Herein, B1R antagonism (R-954) was able to decrease serum creatinine levels, whereas B2R antagonism had no effect. The protection seen under B1R deletion or antagonism was associated with an increased expression of GATA-3, IL-4 and IL-10 and a decreased T-bet and IL-1beta transcription. Moreover, treatment with R-954 resulted in lower MCP-1, and higher HO-1 expression. Our results demonstrated that bradykinin B1R antagonism is beneficial in renal IRI.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 124 127 124 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Thadhani1">[1]</xref>
###xml 280 283 280 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Rabb1">[2]</xref>
###xml 284 287 284 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Marques1">[8]</xref>
Renal ischemia and reperfusion injury (IRI) is a leading cause of acute renal failure in both allografts and native kidneys [1]. Inflammation plays an important role in the pathogenesis of renal IRI, through leukocyte activation and expression of adhesion molecules and cytokines [2]-[8]. Therefore, new therapeutic strategies aiming to reduce this inflammatory response could be beneficial.
###end p 4
###begin p 5
###xml 215 218 215 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Regoli1">[9]</xref>
###xml 325 328 325 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Regoli1">[9]</xref>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Marceau1">[10]</xref>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Marceau2">[11]</xref>
###xml 486 488 486 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Schanstra1">[12]</xref>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Pesquero1">[13]</xref>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Araujo1">[14]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Araujo1">[14]</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-McLean1">[15]</xref>
###xml 707 711 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Dray1">[16]</xref>
###xml 733 737 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-McLean2">[17]</xref>
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Ahluwalia1">[18]</xref>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Perretti1">[19]</xref>
###xml 786 790 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Tiffany1">[20]</xref>
###xml 791 795 791 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Koyama1">[22]</xref>
Bradykinin receptor activation may affect this inflammatory response. Physiological effects of bradykinin are mediated by two transmembrane G-coupled proteins, namely B1 and B2 receptors (B1R and B2R, respectively) [9]. B2R is constitutively expressed under physiological conditions and is responsible for most kinin effects [9]. By contrast, B1R is normally weakly expressed, being strongly up-regulated in the presence of inflammatory stimuli [10], [11] or its natural agonist des-Arg10-Kallidin [12]. Its role after activation remains unclear. Several studies have shown that B1R can influence immune responses by modulating T lymphocytes [13], [14] and leukocyte migration [14], [15] and prostaglandins [16], mast cell mediators [17], cytokines [18], [19] and chemokines production [20]-[22].
###end p 5
###begin p 6
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Chiang1">[23]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Kakoki1">[24]</xref>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Regarding renal IRI, we have previously demonstrated that B1R knockout mice were protected against IRI. In the other hand, B2R antagonism [23] or simultaneous receptor knockouts [24] was shown to be deleterious.
###end p 6
###begin p 7
This study aimed to analyze the impact of bradykinin B1 and B2R antagonism on renal IRI and to determine the influence of these tratments on renal pro and anti-inflammatory molecules expression.
###end p 7
###begin title 8
Methods
###end title 8
###begin title 9
Animals
###end title 9
###begin p 10
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 57 61 <span type="species:ncbi:10090">B1KO</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
Isogenic male B1R, B2R and B1B2R-deficient C57BL/6 mice (B1KO, B2KO and B1B2KO, respectively) aged 8-12 wks (25-28 g) were used. All mice were kindly donated by Prof. Joao Bosco Pesquero of the Biophysics Department of the Federal University of Sao Paulo (UNIFESP), Brazil. All animals were housed in individual and standard cages and had free access to water and food. Wild type C57BL/6 mice (B1B2WT), matched for age and sex, were used as control animals. All procedures were previously reviewed and approved by the internal Ethics Committee of the Institution.
###end p 10
###begin title 11
Experimental Model of Renal IRI
###end title 11
###begin p 12
###xml 46 49 46 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Kelly1">[3]</xref>
###xml 795 799 777 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sham</italic>
###xml 51 55 <span type="species:ncbi:10090">Mice</span>
Surgery was performed as previously described [3]. Mice were briefly anesthetized with Ketamine-Xylazine (Agribrands do Brazil, Sao Paulo, Brazil). A midline incision was made and both renal pedicles were cross-clamped for 45 minutes. During the procedure, animals were kept well hydrated with saline and at a constant temperature (approximately37degreesC) by means of a heating pad device. Subsequently, microsurgery clamps were removed, the abdomen closed and animals placed in single cages, warmed by indirect light until fully recovered from anesthesia. Animals were kept under controlled conditions until sacrifice, according to experimental protocol at 4, 24, 48 and 120 hours after renal reperfusion. Fifteen animals (n = 15) were sacrificed at each time point. To serve as controls, ten sham animals (n = 10) from each group were subjected to the surgical procedure Groups were broken down for technical and scientific purposes to allow 15 surgeries per day, 5 from each group, namely, 15 IRI surgeries or 15 sham-operated animals per day.
###end p 12
###begin title 13
Analysis of Renal Function
###end title 13
###begin p 14
Serum creatinine was used for renal function assessment. Blood samples were collected at 4, 24, 48 and 120 hours post reperfusion from the abdominal inferior cava vein immediately before induced death. Serum samples were analyzed on a Cobas Mira Plus (Roche, Mannhein, Germany), using the modified Jaffe technique.
###end p 14
###begin title 15
Caspase-3 Activity Assay
###end title 15
###begin p 16
Kidneys were collected at 24 hours and homogenized in 1 mL of ice-cold 40 mmol/L Tris-HCl pH 7.6 with 1% triton X-100. Extracted kidneys were centrifuged and supernatants collected. Protein extracts (50 microg) were diluted in 1 mL of protease assay buffer (20 mmol/L Pipes, 100 mmol/L NaCl, 10 mmol/L DTT, 1 mmol/L EDTA, 0.1% CHAPS, 10% sucrose, pH 7.2) containing 10 microL of Ac-DEVD-AFC substrate (PharMingen, BD Biosciences, San Jose, USA) and incubated for 1h at 37degreesC. Samples were analyzed using a fluorimeter (F-2000, Hitachi, Japan) at 505 nm.
###end p 16
###begin title 17
Antagonist and agonist treatments
###end title 17
###begin p 18
###xml 223 224 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 484 491 476 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 502 506 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-GamaLandgraf1">[25]</xref>
###xml 508 512 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-GamaLandgraf2">[26]</xref>
All treatments were administrated i.p. 30 minutes prior to ischemia. For B1R and B2R antagonism, wild-type animals were treated with R-954 or HOE-140 (200 microg/kg), while for B1R agonism, animals were treated with des-Arg9-BK (DABK) at a concentration of 600 microg/kg. Agonist and antagonists were kindly donated by Dr. Pierre Sirois from the Universite de Sherbrooke, Quebec, Canada. All doses were based on two previously published studies that had used these same compounds for in vivo treatment [25], [26].
###end p 18
###begin title 19
Gene Profiles
###end title 19
###begin p 20
###xml 779 786 776 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003050-t001">Table 1</xref>
###xml 1304 1308 1277 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sham</italic>
###xml 1347 1352 1320 1325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;DDCT</sup>
###xml 1460 1464 1433 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sham</italic>
Kidney samples were quickly frozen in liquid nitrogen. Total RNA was isolated by TRIzol Reagent (Invitrogen, California, USA) methodology. First-strand cDNAs were synthesized using MML-V reverse transcriptase (Promega, Madison, USA). Real-time PCR was performed using TaqMan PCR assays as followed: IL-1beta (Mm00434228_m1), IL-4 (Mm00445259_m1), IL-10 (Mm00439616_m1), Bcl-2 (Mm00477631_m1) and Bad (Mm00432042_m1) plus the housekeeper gene hypoxanthine guanine phosphoribosyltransferase (HPRT) (Mm00446968_m1)(Applied Biosystem, California, USA). Real-time PCR was performed for GATA-3, T-bet, MCP-1, HO-1, B1R and B2R expression using SYBR Green assay (Applied Biosystem). In this case, another specific SYBR Green HPRT was used. Sequences of oligonucleotides are depicted in Table 1. Cycling conditions were: 10 minutes at 95degreesC followed by 45 cycles of 30 seconds at 95degreesC, 30 seconds at 58degreesC and 30 seconds at 72degreesC. Relative quantification of mRNA levels was performed using the comparative threshold cycle method (described in detail in User Bulletin 2; PerkinElmer, Applied Biosystems, Branchburg, NJ, 1997). Briefly, the target gene amount was normalized to the endogenous reference (HPRT) and then compared against a calibrator (sample with the lowest expression, namely, sham-operated animals), using the formula 2-DDCT. Hence, all data were expressed as an n-fold difference in relation to the expression of matched controls (sham). Analyses were performed with the Sequence Detection Software 1.9 (SDS).
###end p 20
###begin title 21
Oligonucleotides sequence.
###end title 21
###begin p 22
Oligonucleotides sequence.
###end p 22
###begin title 23
Statistical Analysis
###end title 23
###begin p 24
All data were described as mean+/-S.E.M. Different results among groups were compared using Kruskal-Wallis One Way Analysis of Variance on Ranks (ANOVA) or by the T-test. Results were considered significant when p<0.05. Survival curves were estimated by the Kaplan-Meier test. All statistical analyses were performed with the aid of SigmaStat Statistical Software 2.0 (Jandel Corporation, TX, USA).
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
Bradykinin receptor expression in renal IRI
###end title 26
###begin p 27
###xml 223 232 223 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g001">Figure 1A</xref>
###xml 336 345 336 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g001">Figure 1B</xref>
###xml 0 4 <span type="species:ncbi:10090">B1KO</span>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">B1KO</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
B1KO, B2KO, B1B2KO and wild-type mice were subjected to renal IRI and kidney expression of bradykinin receptors were analyzed at 4, 24, 48 and 120 h of reperfusion. In wild-type mice, receptors expressions were alternated (Figure 1A), suggesting a cross-modulation between them. In B2KO, B1R expression was increased at 4 and 24 hours (Figure 1B). In B1KO mice, B2R expression was not modified (data not shown).
###end p 27
###begin title 28
Renal IRI and bradykinin receptors expression.
###end title 28
###begin p 29
###xml 224 230 224 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 251 257 251 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
Bradykinin receptors were analyzed by real-time PCR. In B1B2WT, receptors expressions were cross-modulated (A). In B2KO, B1R expression was increased at 4 and 24 hours (B). Statistical analyses were performed by ANOVA. *B1R versus B2R, p<0.05. # B2KO versus B1B2WT, p<0.05.
###end p 29
###begin p 30
###xml 125 134 125 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g002">Figure 2A</xref>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Bradykinin receptor importance on survival was also analyzed and mortality of B2KO mice was increased at 120h post ischemia (Figure 2A).
###end p 30
###begin title 31
Animal survival and renal function after bradykinin receptor deletion or antagonism.
###end title 31
###begin p 32
###xml 692 698 688 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 724 730 720 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 759 765 755 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 234 238 <span type="species:ncbi:10090">B1KO</span>
###xml 687 691 <span type="species:ncbi:10090">B1KO</span>
Animal survival was assessed by Kaplan-Meier curve for 5 days after reperfusion. B2KO had the lowest survival at 120 hours of reperfusion (A). Renal function was estimated by serum creatinine levels measured by modified Jaffe method. B1KO protection was observed at all times, while B2KO protection was only seen at 4 and 24 hours (B). Thirty minutes prior to the ischemic insult, wild-type animals were treated with B1R or B2R antagonists (R-954 and HOE-140, respectively, both at 200 microg/kg) via i.p and plasmatic creatinine levels were assayed at 24 hours of reperfusion. Only the R-954 treatment resulted in lower SCr levels (C). Statistical analyses were performed using ANOVA. *B1KO versus B1B2WT, p<0.05 and #B2KO versus B1B2WT, p<0.05. ***IR+R-954 versus IR and IR+HOE-140, p<0.05.
###end p 32
###begin title 33
Modulation of renal function by Bradykinin receptors deletion or antagonism
###end title 33
###begin p 34
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sham</italic>
###xml 233 242 233 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g002">Figure 2B</xref>
All animals subjected to renal ischemia showed a significant rise in serum creatinine levels (sCr) after 4, 24 and 48 hours of reperfusion, in comparison to sham-operated (data not shown). All values returned to normal at 120 hours (Figure 2B).
###end p 34
###begin p 35
###xml 413 419 411 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 524 533 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g002">Figure 2C</xref>
###xml 755 761 749 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 0 4 <span type="species:ncbi:10090">B1KO</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
B1KO had a significant reduction in sCr at all times analyzed, meanwhile B2KO mice presented lower sCr values only at 4 and 24 h. These results showed that B1R deletion was beneficial throughout different reperfusion times; meanwhile protection under B2R absence was only seen at the beginning of this process. Moreover, B1R antagonism (R-954) significantly reduced sCr levels at 24 hours (0.93+/-0.40 in treated versus 2.22+/-0.14 mg/dL in untreated animals, p = 0.005), which was not observed by B2R antagonism (HOE-140) (Figure 2C). Since a significant protection was only achieved by B1R antagonism, we decided to analyze whether its agonist (DABK) would have an impact on renal IRI. In this case, sCr levels were unaffected (2.22+/-0.14 in untreated versus 1.95+/-0.20 mg/dL in treated animals).
###end p 35
###begin title 36
Bradykinin receptors and apoptosis after renal IRI
###end title 36
###begin p 37
###xml 229 238 229 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g003">Figure 3A</xref>
###xml 410 419 410 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g003">Figure 3C</xref>
###xml 203 207 <span type="species:ncbi:10090">B1KO</span>
###xml 356 360 <span type="species:ncbi:10090">B1KO</span>
###xml 458 462 <span type="species:ncbi:10090">B1KO</span>
Cell death was estimated by the anti-apoptotic Bcl-2 and the pro-apoptotic Bad mRNA expression and caspase-3 activity, a central protease in apoptosis that is induced by renal ischemia. We observed that B1KO had increased Bcl-2 (Figure 3A) and decreased Bad (Figure B) expressions compared to wild-type and B2KO animals. Furthermore, caspase-3 activity of B1KO was significantly lower than wild type and B2KO (Figure 3C). These results thereby indicate that B1KO protection was associated with lower apoptosis.
###end p 37
###begin title 38
Cell death modulation under B1R-knockout.
###end title 38
###begin p 39
###xml 417 423 417 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 207 211 <span type="species:ncbi:10090">B1KO</span>
###xml 412 416 <span type="species:ncbi:10090">B1KO</span>
Apoptosis was estimated by Bcl-2 and Bad expression and caspase-3 activity, at 24 hours of reperfusion. Bcl-2 and Bad expression were measured by real-time PCR, and caspase-3 activity by fluorimetric assay. B1KO animals presented higher Bcl-2 expression (A) along with lower Bad expression (B) and caspase-3 activity (C), indicating a lower degree of apoptosis. Statistical analyses were performed using ANOVA.* B1KO versus B1B2WT and B2KO, p<0.05.
###end p 39
###begin title 40
Pro and anti-inflammatory molecule expression in B1R knockout or antagonism after renal IRI
###end title 40
###begin p 41
###xml 259 274 256 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g004">Figure 4a and b</xref>
###xml 292 307 289 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g005">Figure 5a and b</xref>
###xml 418 436 415 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g004">Figure 4c, d and e</xref>
###xml 463 481 460 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g005">Figure 5d, e and f</xref>
###xml 576 580 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Wang1">[27]</xref>
###xml 639 654 636 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g005">Figure 5c and g</xref>
###xml 728 736 725 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g005">Figure 5</xref>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
Pro and anti-inflammatory molecules were measured at 24 hours of reperfusion in B1R knockout or antagonist-treated mice. We observed that the pro-inflammatory transcriptional factor T-bet and the cytokines IL-1beta were significantly reduced by B1R knockout (Figure 4a and b) and antagonism (Figure 5a and b). In the other hand, the anti-inflammatory components GATA-3, IL-4 and IL-10 were increased in knockout mice (Figure 4c, d and e) and R-954 treated group (Figure 5d, e and f). We previously have observed that B1R deletion increased HO-1 and decreased MCP-1 expression [27]. Herein, similar results were achieved by B1R antagonism (Figure 5c and g). B1R agonist was not to modify the expression of any molecule analyzed (Figure 5).
###end p 41
###begin title 42
###xml 49 53 <span type="species:ncbi:10090">B1KO</span>
Pro and anti-inflammatory molecule expression in B1KO and wild type animals.
###end title 42
###begin p 43
###xml 310 316 307 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 84 88 <span type="species:ncbi:10090">B1KO</span>
###xml 305 309 <span type="species:ncbi:10090">B1KO</span>
All molecule expressions were measured by real-time PCR at 24 hours of reperfusion. B1KO group had lower pro-inflammatory molecule expression (T-bet and IL-1beta) (A and B) and higher anti-inflammatory response (GATA-3, IL-4 and IL-10) (C, D and E). Statistical analyses were performed using the t-test.* B1KO versus B1B2WT, p<0.05.
###end p 43
###begin title 44
Pro and anti-inflammatory molecules expression after B1R antagonist and agonist treatment.
###end title 44
###begin p 45
###xml 429 435 426 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
All molecule expressions were estimated by real-time PCR at 24 hours of reperfusion. B1R antagonism (R-954) resulted in lower pro-inflammatory molecule expression (T-bet, IL-1beta and MCP-1) (A, B and C) and higher anti-inflammatory response (GATA-3, IL-4, IL-10 and HO-1) (D, E, F and G). Molecule expression after B1R agonism (DABK) were similar to non-treated mice. Statistical analyses were performed using ANOVA.*IR+HOE-140 versus IR, p<0.05.
###end p 45
###begin p 46
###xml 181 187 179 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 341 362 337 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003050-g006">Figure 6b, c, d and e</xref>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Renal function and the expression of some cytokines were also studied in B1B2KO mice. At 24 hours after IRI, these animals presented high levels of sCr (2.47+/-0.17 mg/dL in B1B2KO versus 2.22+/-0.14 mg/dL in B1B2WT) and thus, they were not protected from injury. They also presented a pro-inflammatory profile similar to wild-type animals (Figure 6b, c, d and e).
###end p 46
###begin title 47
B1B2KO renal function and expression of pro and anti-inflammatory molecules.
###end title 47
###begin p 48
###xml 554 560 551 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
Renal function was estimated by serum creatinine levels measured using the modified Jaffe method. At 24 hours of reperfusion, B1B2KO presented high levels of serum creatinine and they were similar to wild-type mice (A). Thus, no renal protection was observed under simultaneous receptors deletion. Inflammatory molecule expressions were measured by real-time PCR. IL-1beta (B), T-bet (C), IL-4 (D) and IL-10 (E) expressions were similar between the double-knockout strain and wild-type mice. Statistical analyses were performed using the T-test.* B1B2KO versus B1B2WT, p<0.05.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Wang1">[27]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Souza1">[28]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Ni1">[29]</xref>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Duka1">[31]</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Duka1">[31]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Duka2">[32]</xref>
A previous study by our group demonstrated that bradykinin receptors may influence tissue outcome in renal IRI [27]. B2R are constitutively expressed, while B1R are inducible. In the present study, IRI induced B1R expression and a cross-modulation between receptors was observed. Cross-modulation has been previously described in different experimental models of intestinal [28], cardiac [29]-[31] and renal [31], [32] insults.
###end p 50
###begin p 51
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Wang1">[27]</xref>
###xml 111 115 <span type="species:ncbi:10090">B1KO</span>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">B1KO</span>
Our previous work has demonstrated that sCr levels, measured 24 hours after renal ischemia, were much lower in B1KO than in wild-type mice [27]. In this study, B1KO protection was confirmed at all stages. Moreover, we found that B1R antagonist R-954 also able to reduce sCr levels.
###end p 51
###begin p 52
###xml 793 797 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Chiang1">[23]</xref>
###xml 838 842 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Chiang1">[23]</xref>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
Concerning B2R and renal IRI, our previous paper showed that sCr levels were slightly lower in B2KO when compared to wild-type mice. However, this difference did not reach statistical significance. Here, the use of a larger number of B2KO animals resulted in a significant decreased of sCr exclusively at the beginning of reperfusion. In contrast, this protection was not mimicked by B2R antagonism and was not associated with any inflammatory molecule here analyzed. This led us to believe that B2KO protection might rely on expression and function of other molecules not measured here. In agreement with this, a previous study have shown that in renal IRI, early B2R deletion was associated with decreased serum creatine levels, ROS production, cell death and TNF-alpha and MCP-1 expression [23]. However, in the study of Chiang et al. [23] animals were subjected to a less severe IRI, which may explain the slight difference of renal dysfunction and tissue responses between our studies. Even more, they only observed tissue outcome at 24 hours of reperfusion, herein the analyses were made at 4, 24, 48 and 120 hours.
###end p 52
###begin p 53
###xml 398 402 <span type="species:ncbi:10090">B1KO</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">B1KO</span>
The 24-hour post ischemia period is commonly considered as the most deleterious in renal IRI, corresponding with the highest probability of cell death. Serum creatinine levels of all ischemic groups analyzed peaked at this 24 hr period, indicating that maximum renal damage occurred. We evaluated several molecules associated with cell death at 24 hrs and found their expression to be decreased in B1KO mice. Moreover, we found that the renal protection observed in B1KO was associated with a lower degree of apoptosis. Thus, B1R deletion may protect renal cells from death during IRI.
###end p 53
###begin p 54
###xml 176 179 176 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Yokota1">[4]</xref>
###xml 181 184 181 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Rabb2">[6]</xref>
###xml 186 189 186 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Pinheiro1">[7]</xref>
###xml 835 838 828 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Rabb2">[6]</xref>
###xml 840 843 833 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Marques1">[8]</xref>
###xml 845 849 838 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Liu1">[33]</xref>
###xml 850 854 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Yokota2">[35]</xref>
Concerning the immunological aspect of renal IRI, T lymphocytes are considered important mediators of this injury, since T cell depletion significantly improves renal function [4], [6], [7]. In this context, CD4 T cells have been a focus of research due to their differentiation to either a Th1 (pro inflammatory) or a counterbalancing Th2 (anti inflammatory) profile. In renal IRI, animals lacking the transcriptional factor of the Th2 profile (STAT-6) develop more severe renal damage, while deletion of the Th1 transcriptional factor STAT-4 results in mild protection. Furthermore, activation of the Th2 transcriptional factor GATA-3 followed by IL-4, IL-5, IL-6, IL-10 and IL-13 production was shown to be protective, whereas higher expression of the transcriptional factor T-bet, and IL-12, IL-1beta and IFN-gamma was deleterious [6], [8], [33]-[35]. All of these studies point out that tissue outcome after renal IRI may be influenced by anti and pro inflammatory responses.
###end p 54
###begin p 55
###xml 441 445 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Ni1">[29]</xref>
###xml 447 451 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Emanueli1">[36]</xref>
###xml 453 457 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Liesmaa1">[37]</xref>
###xml 664 668 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Souza1">[28]</xref>
###xml 1050 1054 1047 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Liesmaa1">[37]</xref>
###xml 1263 1267 1260 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Dray1">[16]</xref>
###xml 1289 1293 1286 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-McLean1">[15]</xref>
###xml 1322 1326 1316 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Ahluwalia1">[18]</xref>
###xml 1328 1332 1322 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Perretti1">[19]</xref>
###xml 1389 1393 1383 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Tiffany1">[20]</xref>
###xml 1394 1398 1388 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Koyama1">[22]</xref>
###xml 70 74 <span type="species:ncbi:10090">B1KO</span>
###xml 495 498 <span type="species:ncbi:10116">rat</span>
###xml 600 615 <span type="species:ncbi:10090">transgenic mice</span>
###xml 761 766 <span type="species:ncbi:9606">human</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
To investigate possible immunological responses that were involved in B1KO protection, the expression of some anti and pro inflammatory components were analyzed in the kidneys. We found that B1R gene deletion or antagonism resulted in higher expression of the anti-inflammatory GATA-3, IL-4 and IL-10 and lower transcription of the pro-inflammatory T-bet and IL-1beta. Other studies have associated B1R activation with enhanced inflammation [29], [36], [37]. Ni and colleagues demonstrated in a rat model that overexpression of B1 receptors exacerbated paw edema induced by carrageenan, and rendered transgenic mice more susceptible to LPS-induced endotoxic shock [28]. Liesmaa and collaborators identified increased expression of B1R in endothelium of failing human hearts. They demonstrated that B1R knockout mice, in contrast to B2R knockout mice, did not spontaneously develop heart failure and presented an altered inflammatory response, suggesting that B1R play an essential role in the initiation of inflammation following myocardial ischemia [37]. Engagement of the B1R has pro-inflammatory effects, including promotion of leukocyte traffic, edema and pain. Moreover, it has been demonstrated that B1R activation can enhance the release of prostaglandins [16], mast cell mediators [15], cytokines, mainly IL-1beta [18], [19] and chemokines and leukotrienes in different cell types [20]-[22].
###end p 55
###begin p 56
Our results suggest a major influence of B1R in renal ischemia, since treatment with its antagonist resulted in functional improvement. B1R antagonist also changed the profile of pro and anti inflammatory molecules, whose expression was induced by IRI. Animals treated with R-954 showed an increased anti-inflammatory cytokine profile, whereby GATA-3, IL-4 and IL-10 were up regulated while T-bet and IL-1beta expressions were down regulated.
###end p 56
###begin p 57
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Wang1">[27]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Feitoza1">[38]</xref>
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Yet1">[39]</xref>
###xml 636 640 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Sacerdoti1">[40]</xref>
###xml 186 190 <span type="species:ncbi:10090">B1KO</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
Even more, the expression of MCP-1 was reduced while HO-1 was up regulated by B1R antagonism, confirming previous observations from our group that showed a similar expression profile in B1KO mice [27]. Ischemic organ outcome is determined mainly by the tuned balance between aggression and cytoprotection. HO-1 is a protective enzyme able to generate carbon monoxide (CO), biliverdin and free iron, through heme metabolism (reviewed in Camara NO and Soares MP, 2005 [38]), which can be protective against ischemic insults [39]. Sacerdoti and colleagues have recently demonstrated that HO-1 expression is inversely correlated with MCP-1 [40].
###end p 57
###begin p 58
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Duka2">[32]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Kakoki1">[24]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003050-Kakoki1">[24]</xref>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
Herein, we also showed that simultaneous deletion of both receptors resulted in extremely high levels of sCr and in a pro-inflammatory profile. In concordance with this, worse prognoses of double knockout mice were also observed in pancreas [32] and in another study of renal [24] IRI. Kakoki et al. linked this deleterious effect to an enhanced pattern of oxidative stress [24]. Here, we demonstrated that B1B2KO mice expressed a pro-inflammatory phenotype that might explain part of their renal dysfunction.
###end p 58
###begin p 59
Taken together, our results showed that the protection found under B1R gene deletion or antagonism involves a shift towards an anti-inflammatory profile, concomitant with down regulation of pro-inflammatory molecules and upregulation of anti-inflammatory ones. Since B1R antagonism proved to be protective, we believe that this may represent a new therapeutic strategy against renal IRI.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
Acute renal failure.
###end article-title 61
###begin article-title 62
Leukocytes, cell adhesion molecules and ischemic acute renal failure.
###end article-title 62
###begin article-title 63
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury.
###end article-title 63
###begin article-title 64
###xml 41 47 <span type="species:ncbi:10090">murine</span>
Protective effect of T cell depletion in murine renal ischemia-reperfusion injury.
###end article-title 64
###begin article-title 65
T cells as mediators in renal ischemia/reperfusion injury.
###end article-title 65
###begin article-title 66
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice.
###end article-title 66
###begin article-title 67
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Contribution of CD4+ T cells to the early mechanisms of ischemia- reperfusion injury in a mouse model of acute renal failure.
###end article-title 67
###begin article-title 68
Influence of TH1/TH2 switched immune response on renal ischemia-reperfusion injury.
###end article-title 68
###begin article-title 69
Pharmacology of bradykinin and related kinins.
###end article-title 69
###begin article-title 70
Kinin receptors.
###end article-title 70
###begin article-title 71
The B1 receptors for kinins.
###end article-title 71
###begin article-title 72
###xml 155 160 <span type="species:ncbi:9606">human</span>
The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.
###end article-title 72
###begin article-title 73
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors.
###end article-title 73
###begin article-title 74
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Altered neutrophil homeostasis in kinin B1 receptor-deficient mice.
###end article-title 74
###begin article-title 75
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
Association between kinin B(1) receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules.
###end article-title 75
###begin article-title 76
Bradykinin and inflammatory pain.
###end article-title 76
###begin article-title 77
Role of kinin B1 and B2 receptors and mast cells in post intestinal infection-induced hypersensitivity to distension.
###end article-title 77
###begin article-title 78
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
Calcitonin gene-related peptides modulate the acute inflammatory response induced by interleukin-1 in the mouse.
###end article-title 78
###begin article-title 79
Pharmacology of interleukin-1-induced neutrophil migration.
###end article-title 79
###begin article-title 80
Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages.
###end article-title 80
###begin article-title 81
Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity.
###end article-title 81
###begin article-title 82
Bradykinin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity.
###end article-title 82
###begin article-title 83
Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury.
###end article-title 83
###begin article-title 84
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury.
###end article-title 84
###begin article-title 85
Modulation of allergic and immune complex-induced lung inflammation by bradykinin receptor antagonists.
###end article-title 85
###begin article-title 86
###xml 27 33 <span type="species:ncbi:10090">murine</span>
Differential modulation of murine lung inflammation by bradykinin B1 and B2 selective receptor antagonists.
###end article-title 86
###begin article-title 87
Influence of bradykinin B1 and B2 receptors in the immune response triggered by renal ischemia-reperfusion injury.
###end article-title 87
###begin article-title 88
Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury.
###end article-title 88
###begin article-title 89
Overexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammation.
###end article-title 89
###begin article-title 90
Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction.
###end article-title 90
###begin article-title 91
Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension.
###end article-title 91
###begin article-title 92
Mechanisms mediating the vasoactive effects of the B1 receptors of bradykinin.
###end article-title 92
###begin article-title 93
###xml 45 51 <span type="species:ncbi:10090">murine</span>
A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity.
###end article-title 93
###begin article-title 94
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection.
###end article-title 94
###begin article-title 95
###xml 70 76 <span type="species:ncbi:10090">murine</span>
Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury.
###end article-title 95
###begin article-title 96
Targeting kinin B(1) receptor for therapeutic neovascularization.
###end article-title 96
###begin article-title 97
###xml 106 111 <span type="species:ncbi:9606">human</span>
Increased expression of bradykinin type-1 receptors in endothelium of intramyocardial coronary vessels in human failing hearts.
###end article-title 97
###begin article-title 98
Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury.
###end article-title 98
###begin article-title 99
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice.
###end article-title 99
###begin article-title 100
Heme oxygenase-1 transduction in endothelial cells causes downregulation of monocyte chemoattractant protein-1 and of genes involved in inflammation and growth.
###end article-title 100
###begin p 101
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 101
###begin p 102
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) and CNPq. Grant numbers: 04/08311-6, 05/50085-6, 06/03982-5 and 07/07139-3
###end p 102

